Hepatitis B Virus Replication in CD34+ Hematopoietic Stem Cells From Umbilical Cord Blood

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2016 May 19

PMID 27188537

Citations 8

Authors

Yanxin Huang

Qin Yan

Rongshan Fan

Shupeng Song

Hong Ren

Yongguo Li

Yinghua Lan

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Hepatitis B virus (HBV) is a hepatotropic virus that can infect extrahepatic tissue. Whether hematopoietic stem cells (HSCs) can be infected by HBV and serve as a potential virus reservoir is still unknown. In this study, the susceptibility of CD34+ HSCs to HBV was investigated. MATERIAL AND METHODS Cord blood-derived CD34+ HSCs were exposed to HBV in vitro, and immunocytochemistry, transmission electron microscopy, and RT-PCR were used to identify viral-related proteins and specific viral genomic sequences. Then, CD34+ HSCs were challenged by different titers of HBV, and intracellular and supernatant HBV DNA, and hepatitis B surface antigen (HBsAg) levels, were examined. In addition, CD34+ peripheral blood stem cells (PBSCs) from chronic HBV carriers were isolated and cultured, and HBV DNA levels were measured. RESULTS HBV-infected CD34+ cells showed positive signals for HBsAg by DAB staining and TRITC staining, and HBV particles were identified. RT-PCR results showed that the 403 bp PCR products corresponding to the amplified hepatitis B S gene fragment were observed in CD34+ HSCs infected by HBV. In addition, supernatant and intracellular HBV DNA increased with the proliferation of CD34+ HSCs. Similar results were obtained from intracellular HBsAg quantification tests. In addition, HBV DNA levels both in cells and in supernatants of CD34+ PBSCs increased proportionally, and the increments of HBV DNA in the supernatants paralleled those found in cells. CONCLUSIONS HBV can replicate in CD34+ HSCs in cord blood or peripheral blood of chronic HBV carriers.

Citing Articles

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis.

Svicher V, Salpini R, DAnna S, Piermatteo L, Iannetta M, Malagnino V Front Oncol. 2023; 13:1143258.

PMID: 37007163 PMC: 10050604. DOI: 10.3389/fonc.2023.1143258.

Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo.

Karamichali E, Foka P, Papadopoulou G, Loukaki-Gkountara D, Andresaki K, Koskinas I Int J Mol Sci. 2022; 23(18).

PMID: 36142773 PMC: 9505460. DOI: 10.3390/ijms231810862.

Hepadnaviral Lymphotropism and Its Relevance to HBV Persistence and Pathogenesis.

Coffin C, Mulrooney-Cousins P, Michalak T Front Microbiol. 2021; 12:695384.

PMID: 34421849 PMC: 8377760. DOI: 10.3389/fmicb.2021.695384.

Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies.

Konopleva M, Belenikin M, Shanko A, Bazhenov A, Kiryanov S, Tupoleva T Diagnostics (Basel). 2021; 11(6).

PMID: 34072185 PMC: 8228241. DOI: 10.3390/diagnostics11060969.

Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis.

Lau K, Burak K, Coffin C Microorganisms. 2020; 8(10).

PMID: 32987867 PMC: 7599633. DOI: 10.3390/microorganisms8101470.

References

Shi Y, Lan Y, Cao F, Teng Y, Li L, Wang F . Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients. J Viral Hepat. 2014; 21(7):e39-47. PMC: 4237112. DOI: 10.1111/jvh.12236. View

Chiba T, Yokosuka O, Goto S, Fukai K, Imazeki F, Shishido H . Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine. Eur J Haematol. 2003; 71(3):220-3. DOI: 10.1034/j.1600-0609.2003.00114.x. View

Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z . TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012; 8(3):e1002594. PMC: 3305436. DOI: 10.1371/journal.ppat.1002594. View

Zhang L, Gui X, Teter C, Zhong H, Pang Z, Ding L . Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Vaccine. 2014; 32(46):6091-7. DOI: 10.1016/j.vaccine.2014.08.078. View

Rong Q, Huang J, Su E, Li J, Li J, Zhang L . Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells. Virol J. 2007; 4:36. PMC: 1851702. DOI: 10.1186/1743-422X-4-36. View

McNamara L, Collins K . Hematopoietic stem/precursor cells as HIV reservoirs. Curr Opin HIV AIDS. 2011; 6(1):43-8. PMC: 3045752. DOI: 10.1097/COH.0b013e32834086b3. View

LAMELIN J, Zoulim F, Trepo C . Lymphotropism of hepatitis B and C viruses: an update and a newcomer. Int J Clin Lab Res. 1995; 25(1):1-6. DOI: 10.1007/BF02592570. View

Ilan Y, Nagler A, Adler R, Tur-Kaspa R, Slavin S, Shouval D . Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor. Gastroenterology. 1993; 104(6):1818-21. DOI: 10.1016/0016-5085(93)90664-x. View

Pontisso P, Vidalino L, Quarta S, Gatta A . Biological and clinical implications of HBV infection in peripheral blood mononuclear cells. Autoimmun Rev. 2008; 8(1):13-7. DOI: 10.1016/j.autrev.2008.07.016. View

10.

Elfassi E, Essex M, Haseltine W . Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus. Proc Natl Acad Sci U S A. 1984; 81(11):3526-8. PMC: 345541. DOI: 10.1073/pnas.81.11.3526. View

11.

Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y . Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003; 71(3):360-6. DOI: 10.1002/jmv.10493. View

12.

Hui C, Lie A, Au W, Leung Y, Ma S, Cheung W . A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood. 2005; 106(2):464-9. DOI: 10.1182/blood-2005-02-0698. View

13.

Rehermann B, Nascimbeni M . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5(3):215-29. DOI: 10.1038/nri1573. View

14.

Dienstag J . Hepatitis B virus infection. N Engl J Med. 2008; 359(14):1486-500. DOI: 10.1056/NEJMra0801644. View

15.

Op den Brouw M, Binda R, van Roosmalen M, Protzer U, Janssen H, van der Molen R . Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology. 2008; 126(2):280-9. PMC: 2632689. DOI: 10.1111/j.1365-2567.2008.02896.x. View

16.

Ma R, Xing Q, Shao L, Wang D, Hao Q, Li X . Hepatitis B virus infection and replication in human bone marrow mesenchymal stem cells. Virol J. 2011; 8:486. PMC: 3225454. DOI: 10.1186/1743-422X-8-486. View

17.

STEINBERG H, BOUFFARD P, Trepo C, Zeldis J . In vitro inhibition of hemopoietic cell line growth by hepatitis B virus. J Virol. 1990; 64(6):2577-81. PMC: 249434. DOI: 10.1128/JVI.64.6.2577-2581.1990. View

18.

Sing G, Prior S, Fernan A, Cooksley G . Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells. J Virol. 1993; 67(6):3454-60. PMC: 237691. DOI: 10.1128/JVI.67.6.3454-3460.1993. View

19.

Ye B, Liu X, Li X, Kong H, Tian L, Chen Y . T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis. 2015; 6:e1694. PMC: 4385920. DOI: 10.1038/cddis.2015.42. View

20.

Zeldis J, Mugishima H, Steinberg H, Nir E, Gale R . In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest. 1986; 78(2):411-7. PMC: 423568. DOI: 10.1172/JCI112591. View